Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smolen, G. A.
Right arrow Articles by Haber, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smolen, G. A.
Right arrow Articles by Haber, D. A.
[Cancer Research 64, 7846-7851, November 1, 2004]
© 2004 American Association for Cancer Research


Regular Articles

SUMO-1 Modification of the Wilms’ Tumor Suppressor WT1

Gromoslaw A. Smolen1, Maria T. Vassileva2, Julie Wells1, Michael J. Matunis2 and Daniel A. Haber1

1 Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts; and 2 Department of Biochemistry and Molecular Biology, Bloomberg School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland

SUMO-1 conjugation modulates numerous cellular functions, including the subnuclear localization of its target proteins. The WT1 tumor suppressor encodes a four-zinc finger protein with distinct splicing isoforms. WT1(–KTS), encoding uninterrupted zinc fingers, functions as a transcription factor and has a diffusely nuclear distribution; WT1(+KTS), with an insertion of three amino acids (KTS) between zinc fingers three and four, localizes to discrete nuclear speckles, the function of which is unknown. Because the SUMO-1 E2-conjugating enzyme, Ubc9, interacts with WT1, we tested whether sumoylation modulates the cellular localization of WT1. We find here that both WT1 isoforms are directly sumoylated on lysine residues 73 and 177. Although RNA interference-mediated Ubc9 depletion effectively suppresses WT1 nuclear speckles, a SUMO-1–deficient WT1(+KTS)(K73, 177R) double mutant retains localization to speckles. Thus, direct sumoylation of WT1 is not responsible for its cellular localization, and other sumoylated proteins may target WT1 to these nuclear structures. Identification of other components of WT1-associated speckles is likely to provide clues to their function.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
A. Jakobs, F. Himstedt, M. Funk, B. Korn, M. Gaestel, and R. Niedenthal
Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation
Nucleic Acids Res., September 27, 2007; 35(17): e109 - e109.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
D. Mukhopadhyay, F. Ayaydin, N. Kolli, S.-H. Tan, T. Anan, A. Kametaka, Y. Azuma, K. D. Wilkinson, and M. Dasso
SUSP1 antagonizes formation of highly SUMO2/3-conjugated species
J. Cell Biol., September 25, 2006; 174(7): 939 - 949.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.